ArticleBMC cardiovascular disorders2026
Clinical profiles, management, and outcomes of acute coronary syndrome patients in hospitals without reperfusion therapy: a multicentre study in Addis Ababa, Ethiopia.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute coronary syndrome (ACS) is a leading cause of morbidity and mortality worldwide, disproportionately affecting low- and middle-income countries. Although ACS has been studied in Ethiopia, there is limited evidence on patients managed without reperfusion therapy, particularly across multiple tertiary public hospitals. This study aimed to assess the clinical profiles, in-hospital management, and outcomes of non-reperfused ACS patients in a multicentre Ethiopian setting.
methodsWe conducted a multicentre retrospective study of adult ACS patients admitted to three tertiary public hospitals in Addis Ababa, Ethiopia, between February 25, 2023, and August 31, 2024, where reperfusion therapy was unavailable. All eligible patients were consecutively included. ACS included unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction, diagnosed based on ischemic symptoms, elevated troponins, ECG changes (new ST/T-wave changes, new left bundle branch block, or pathological Q-waves), and/or imaging evidence of myocardial injury or regional wall motion abnormalities. Clinical characteristics, management, and outcomes were extracted from electronic health records. Data were analyzed using SPSS version 26 and multivariable logistic regression was used to identify factors associated with in-hospital mortality (P < 0.05).
resultsA total of 154 ACS patients were included (mean age 58.4 ± 12.2 years; 63.6% male), with STEMI accounting for 79.9%. The median time from symptom onset to hospital arrival was 24 h (IQR 11.5–72.0). Chest pain (87.7%, typical in 53.2%) and shortness of breath (50.6%) were the most common presenting symptoms. Hypertension (55.2%) and diabetes (44.2%) were the most frequent comorbidities. Most patients received dual antiplatelet therapy (98.7%), statins (94.8%), and therapeutic anticoagulation (90.3%). The in-hospital mortality rate was 26.6%, with a median hospital stay of 8 days (IQR 4–10). Independent predictors of mortality were older age (AOR 1.04; 95% CI 1.00–1.09), female sex (AOR 3.90; 95% CI 1.40–10.93), higher respiratory rate (AOR 1.18; 95% CI 1.04–1.35), and lower systolic blood pressure (AOR 0.97; 95% CI 0.95–0.99).
conclusionsThis study demonstrated a high rate of in-hospital mortality among ACS patients in hospitals without reperfusion therapies. Older age, female sex, higher respiratory rate, and lower systolic blood pressure were independently associated with mortality, emphasizing the importance of early risk assessment and vigilant monitoring of vital signs. Expanding the availability of thrombolysis, implementing structured prehospital ACS education programs, and establishing standardized ACS care pathways are imperative to achieving optimal outcomes in resource-limited settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.